Sign In/ Sign Up
Dr. Nadia Lanker
Jun 25, 2016
New diabetes drug adversely affects 3 for first time in India
For the first time ever, adverse drug reactions associated with the use of a new class of anti-diabetes medicine (SGLT-2 inhibitors) have been reported from India. Three patients who had been prescribed the new class of anti-diabetes therapy have reported certain complications called ketonemia, where the body produces high levels of blood acids (ketones) that may also require hospitalisation...
New diabetes drug adversely affects 3 for first time in India | ET HealthWorld
Though there have been three adverse drug reactions reported till now, doctors say there may be likely additional cases about which they may be unawar..